基于卡氏功能状态评分的风险评分可改善撒哈拉以南非洲脓毒症出院后死亡预测:一项来自乌干达的多队列研究
该研究分析乌干达 Entebbe 和 Tororo 两家公立医院的两个前瞻性观察队列,纳入因脓毒症住院后存活出院或转院的成人(≥18 岁)。出院或转院当天由研究临床医生评估 KPS,分别于出院后 30 天(Entebbe,n=217)和 60 天(Tororo,n=251)确认生存状态。在两个队列中,校正人口学、住院生理严重程度、高负担合并感染和住院时长后,出院时 KPS 越高与出院后死亡 odds 降低显著相关(校正 OR 分别为 0.95 [95%CI 0.93-0.98] 和 0.96 [95%CI 0.94-0.98])。将 KPS 加入包含上述变量的基线风险模型后,两个队列的出院后死亡预测均显著改善,预测区分度和校准度也改善。作者认为,将 KPS 纳入出院计划可能有助于指导针对性干预以改善中低收入国家的脓毒症存活者预后。
要点
- 在乌干达两个脓毒症存活者队列中,出院时 KPS 越高,校正后出院后死亡 odds 越低:Entebbe 校正 OR 0.95(95%CI 0.93-0.98),Tororo 校正 OR 0.96(95%CI 0.94-0.98)。
- 将出院时 KPS 加入包含人口学、住院生理严重程度、高负担合并感染和住院时长的基线风险模型,两个队列的出院后死亡预测均显著改善。
- 加入 KPS 后,两个队列的预测区分度和校准度也均改善。
- 研究纳入标准为成人(≥18 岁)因脓毒症住院(感染征象且 quick Sepsis-related Organ Failure Assessment 评分≥1)并存活出院或转院者。
- 作者认为,将 KPS 纳入出院计划可能有助于指导针对性干预,以改善中低收入国家的脓毒症存活者预后。
适用人群与场景
- 纳入标准:成人(≥18 岁)因脓毒症住院,脓毒症定义为感染征象且 quick Sepsis-related Organ Failure Assessment 评分≥1,并存活出院或转院者。
- 研究场景:乌干达 Entebbe 和 Tororo 两家公立医院,出院后随访阶段。
- Entebbe 队列 n=217,出院后 30 天确认生存状态;Tororo 队列 n=251,出院后 60 天确认生存状态。
诊断标准与关键阈值
- 脓毒症定义:感染征象且 quick Sepsis-related Organ Failure Assessment 评分≥1。
- KPS 于出院或转院当天由研究临床医生评估。
研究设计与关键结果
- 研究设计:分析乌干达两个前瞻性观察队列(Entebbe n=217,Tororo n=251),纳入存活出院或转院的成人脓毒症患者,无干预。
- 主要结果:校正人口学、住院生理严重程度、高负担合并感染和住院时长后,出院或转院时 KPS 越高与出院后死亡 odds 降低显著相关,Entebbe 校正 OR 0.95(95%CI 0.93-0.98),Tororo 校正 OR 0.96(95%CI 0.94-0.98)。
- 将 KPS 加入包含上述变量的基线风险模型后,两个队列的出院后死亡预测均显著改善,预测区分度和校准度也改善。
- 随访时点:Entebbe 队列出院后 30 天,Tororo 队列出院后 60 天。
证据类型、等级与局限
- 证据类型:两个前瞻性观察队列的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,将出院时 KPS 纳入出院计划可能有助于指导针对性干预,以改善中低收入国家的脓毒症存活者预后。
- 研究显示,出院时 KPS 可改善对脓毒症存活者出院后死亡的预测,两个队列校正 OR 分别为 0.95(95%CI 0.93-0.98)和 0.96(95%CI 0.94-0.98)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis survivors worldwide face a high risk of death after hospitalization. In sub-Saharan Africa, where nearly 40% of all sepsis cases occur, post-discharge mortality is a major contributor to poor sepsis outcomes. In this context, stratification of sepsis survivors at high risk for post-discharge mortality is needed to guide targeted follow-up care. We sought to determine the performance of Karnofsky Performance Status (KPS)-based risk stratification for predicting post-discharge mortality among adults surviving sepsis hospitalization in Uganda.
DESIGN: Analysis of two prospective observational cohorts in Uganda.
SETTING: Two public hospitals in Entebbe and Tororo, Uganda.
PATIENTS: Adults (≥ 18 yr) hospitalized with sepsis, defined by signs of infection and quick Sepsis-related Organ Failure Assessment score greater than or equal to 1, who were discharged or transferred alive from the hospital.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: KPS was assessed on the day of discharge or transfer by study clinicians. Vital status was ascertained at 30 and 60 days post-discharge in the Entebbe ( n = 217) and Tororo ( n = 251) cohorts, respectively. In both cohorts, higher KPS scores at discharge or transfer were significantly associated with reduced odds of post-discharge mortality after adjustment for demographics, inpatient physiologic severity, high-burden co-infections and duration of hospitalization (adjusted odds ratios, 0.95 [95% CI, 0.93-0.98] and 0.96 [95% CI, 0.94-0.98] in Entebbe and Tororo, respectively). Adding KPS to a baseline risk model including the above variables significantly improved post-discharge mortality prediction in both cohorts; predictive discrimination and calibration were also improved.
CONCLUSIONS: KPS assessed at hospital discharge significantly improves prediction of post-discharge mortality among acute sepsis survivors in sub-Saharan Africa. Incorporating KPS into discharge planning may help guide targeted interventions to improve sepsis survivorship in low- and middle-income countries.
参考来源
- Videlefsky DS, Lutwama JJ, Owor N, et al. A Karnofsky Performance Status-Based Risk Score Improves Prediction of Post-Sepsis Mortality in Sub-Saharan Africa: A Multicohort Study From Uganda. Crit Care Med. 2026. PMID: 41575299. doi:10.1097/CCM.0000000000007036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。